The CDDF provides a neutral forum to facilitate interactions between all stakeholders (academia, regulatory authorities, policymakers, industry, patient advocacy groups and health technology assessors) to improve the efficiency of cancer drug development. The Association has strived to leverage the insightful discussion of the most promising advances in oncology drug development, uniting experts from various fields.
With collaborative efforts and multi-stakeholder approach, it aims to accelerate the delivery of effective oncology agents to patients, which leads to patients’ quality of life. Discover our multi-stakeholder discussions here: